期刊文献+

雌激素对甲状腺乳头状癌细胞生长的影响及其机制 被引量:1

Effect of estrogen on the growth of papillary thyroid carcinoma cells and its mechanism
原文传递
导出
摘要 目的 观察雌激素对甲状腺乳头状癌BHP10-3细胞株生长的影响,并探讨其机制.方法 将生长良好的BHP10-3细胞根据随机数字表法分为实验组和对照组,实验组加入浓度为10-8mol/L的雌激素,对照组加入等量磷酸盐缓冲液(PBS),噻唑蓝(MTT)测定BHP10-3细胞增殖,流式细胞仪测定BHP10-3细胞周期,Transwell侵袭迁移实验测定BHP10-3细胞侵袭迁移能力,聚合酶链反应(PCR)测定BHP10-3细胞人端粒酶反转录酶(hTERT)、细胞周期蛋白D1(Cyclin D1)、G蛋白耦联雌激素受体1(GPER1)、趋化因子受体1(CXCR1) mRNA表达量,Western blot测定BHP10-3细胞hTERT、Cyclin D1、GPER1、CXCR1蛋白表达量.结果 实验组BHP10-3细胞的增殖率[(18.34±1.67)%]明显高于对照组[(0.00±0.01)%,t=21.533,P=0.000].实验组BHP10-3细胞G1期细胞比例[(60.32±6.57)%]低于对照组[(71.21±8.44)%,t=4.153,P=0.004],实验组BHP10-3细胞S/G2期细胞比例[(37.48±3.12)%]高于对照组[(28.79±2.53)%,t=4.568,P=0.000].实验组侵袭细胞数[(42.31±4.35)个]和迁移细胞数[(46.51±4.57)个]均明显高于对照组[(17.35±2.54)个、(19.54±3.69)个;t=24.353,P=0.000;t=26.542,P=0.000).实验组 BHP10-3细胞hTERT、Cyclin D1、GPER1、CXCR1 mRNA表达量(2.23±0.04、1.87±0.05、2.64±0.07、3.21±0.05) 均明显高于对照组(1.00±0.02、1.00±0.01、1.00±0.01、1.00±0.02;t=3.024,P=0.007;t=2.895,P=0.021;t=3.253,P=0.010;t=3.327,P=0.008).实验组BHP10-3细胞hTERT、Cyclin D1、GPER1、CXCR1蛋白表达量(0.47±0.04、0.39±0.04、0.78±0.05、0.68±0.06) 均明显高于对照组(0.26±0.06、0.17±0.02、0.42±0.03、0.24±0.01;t=4.142,P=0.000;t=3.758,P=0.002;t=3.462,P=0.001;t=5.036,P=0.000).结论 雌激素能够促进甲状腺乳头状癌BHP10-3细胞的增殖和侵袭转移,其机制可能与雌激素能够促进BHP10-3细胞hTERT、Cyclin D1、GPER1、CXCR1的表达量增加有关. Objective To observe the effect of estrogen on the growth of papillary thyroid carcinoma cells, and to investigate its mechanism.Methods The well-grown BHP10-3 cells were divided into experimental group and control group according to random nubmer methods.The experimental group was added estradiol with concentration being 10-8 mol/L, the control group received the same amount of phosphate buffer (PBS) solution.The proliferation of BHP10-3 cells was detected by methyl thiazol tetrazolium (MTT) assay.The cell cycle of BHP10-3 cells was determined by flow cytometry.The invasion and migration ability of BHP10-3 cells were measured by Transwell invasion and migration assay.The human telomerase reverse transcriptase (hTERT) mRNA, Cyclin D1 mRNA, G protein coupled estrogen receptor 1 (GPER1) mRNA and chemokine receptor 1 (CXCR1) mRNA in BHP10-3 cells were determined by polymerase chain reaction (PCR).The protein expressions of hTERT, Cyclin D1, GPER1 and CXCR1 in BHP10-3 cells were detected by Western blotting.Results The proliferation rate of BHP10-3 cells [(18.34±1.67)%] in the experimental group was significantly higher than that in the control group [(0.00±0.01)%, t=21.533, P=0.000].The percentage of G1 phase [(60.32±6.57)%] of BHP10-3 cells in the experimental group was lower than that of the control group [(71.21±8.44)%, t=4.153, P=0.004].The S/G2 phase of BHP10-3 cells in the experimental group was higher than that in the control group [(37.48±3.12)%, (28.79±2.53)%, t=4.568, P=0.000].The invasive cells (42.31±4.35) and migrating cells (46.51±4.57) in the experimental group were significantly higher than those in the control group (17.35±2.54, 19.54±3.69;t=24.353, P=0.000;t=26.542, P=0.000).The expression levels of hTERT mRNA, Cyclin D1 mRNA, GPER1 mRNA and CXCR1 mRNA in BHP10-3 cells (2.23±0.04, 1.87±0.05, 2.64±0.07, 3.21±0.05) were significantly higher than those in the control group (1.00±0.02, 1.00±0.01, 1.00±0.01, 1.00±0.02;t=3.024, P=0.007;t=2.895, P=0.021;t=3.253, P=0.010;t=3.327, P=0.008).The expression levels of hTERT protein, Cyclin D1 protein, GPER1 protein and CXCR1 protein in BHP10-3 cells (0.47±0.04, 0.39±0.04, 0.78±0.05, 0.68±0.06)were significantly higher than those in the control group (0.26±0.06, 0.17±0.02, 0.42±0.03, 0.24±0.01;t=4.142, P=0.000;t=3.758, P=0.002;t=3.462, P=0.001;t=5.036, P=0.000).Conclusion Estrogen can promote the proliferation and invasion and metastasis of papillary thyroid carcinoma BHP10-3 cells, and its mechanism may be related to the estrogen can promote the hTERT, Cyclin D1, GPER1 and CXCR1 expression increased in BHP10-3 cells.
作者 方铁 王一凡
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2017年第3期395-397,共3页 Chinese Journal of Experimental Surgery
关键词 雌激素 甲状腺乳头状癌 细胞 增殖 侵袭 Estrogen Papillary thyroid carcinoma Cell Proliferation Invasion
  • 相关文献

参考文献3

二级参考文献41

  • 1Kansakar E, Chang YJ, Mehrabi M, et ah Expression of estrogen recep- tor,progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer. Am Surg,2009,75:785-789.
  • 2Kawabata W, Suzuki T, Moriya T, et al. Estrogen receptors ( aandl3 ) and 17-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disor-ders:possible in situ estrogen synLesJs ad actions. Mod PatboJ, 2003,16:437-444.
  • 3Zeng Q, (]hen GG, Vlantis AC, et al. The eofitfibutions of oestrogen re- ceptor isoforms to'the development of papillary and anaplastic thyroid carcinomas. J Pathol, 2008,214:425-433.
  • 4Cho MA, Lee MK, Nam KH, eta]. Expression and role of estrogen reeeptor(xandin medullary thyroid carcinoma:different roles in cancer growth and apoptosis. J Endoerino],2007 ,195 :255-263.
  • 5Lange CA. Challenges to defining a role for progesterone in breast cancer. Steroids, 2008,73 : 914 -921.
  • 6Jacobsen BM, Richer JK, Schittone SA, et al. New human breast canc- er cells to study progesterone receptor isoform ratio effects and ligand- independent gene regulation. J Bio Chem,2002,277:27793-27800.
  • 7Camevale RP, Proietti C J, Salatino M, et al. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol, 2007,21 : 1335-1358.
  • 8Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity [J]. Future Oncol, 2010, 6(11) : 1771 -1779.
  • 9Fraser S P, Ozerlat-Gunduz I, Onkal R, et al. Estrogen and non-ge- nomic upregulation of voltage-gated Na( + ) channel activity in MDA- MB-231 human breast cancer cells: role in adhesion[ J]. J Cell Physi- ol, 2010, 224(2) : 527 -539.
  • 10He Y Y, Cai B, Yang Y X, et al. Estrogenic G protein-coupled recep- tor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway [ J ]. Cancer Sci, 2009, 100(6) : 1051 - 1061.

共引文献9

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部